STORIES OF TRANSFORMATION | In recent years, as capital allocators seek to significantly expand their exposure to sustainable investing, Natural Capital is rapidly emerging as an asset class that can offer a unique combination of financial returns, risk mitigation, and positive environmental impact. While its economic contribution is significant –
STORIES OF TRANSFORMATION | Last year, global investment in the low-carbon energy transition hit a record $2.1tn, according to Energy Transition Investment Trends 2025. But, while investment is at an all-time high, growth is slowing – a concerning trend considering a total of $200tn (about $7tn per year) is needed
STORIES OF TRANSFORMATION | Investments in agriculture faced a challenging year in 2024, continuing the steep downturn that began in 2023. In August, the aggregate deal value had fallen 48.7% year-on-year to around $1.5bn from just over $3bn – according to S&P Global Market Intelligence. In contrast, the total aggregate
Risk has always been bread and butter for venture capital (VC) managers – the last year has tested this appetite more than ever. This report examines the most pressing challenges facing managers, the resurgence of tech as the dominant source of returns, and strategies to build more secure and better
US private equity firm Paine Schwartz Partners has a made a AUD1.4 billion ($934.50 billion) bid to acquire the remaining shares it doesn’t already hold in Australian horticultural specialist Costa Group Holdings, according to a report by Reuters.
New advances in artificial intelligence are creating a buzz in tech M&A in 2023, that if backed up by capital deployment could make up for the dip in private investment into the sector in 2022.
Private credit funds could become a more permanent fixture in tech’s leveraged buyout market thanks to their speed of execution and reliability, especially in challenging macroeconomic conditions.
The tech buyout market has watched deal activity take a downward trend through Q1 2023. But there are signs a new valuation environment is turning back in its favour.
Vertex Ventures HC has launched its third and largest fund, the $200 million Fund III, which will be deployed to support life sciences and medical technology companies “aiming to drive innovation and improve patient outcomes”.
HSBC’s purchase of Silicon Valley Bank’s UK arm and government attempts to foster innovation outside the capital are drawing greater attention to the country’s VC ecosystem
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
